FindTrial
Sign In

Covid 19 associated black fungus of nose and eyes

Covid associated Rhino-orbital mucormycosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034337
Enrollment
70
Registered
2021-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B461- Rhinocerebral mucormycosis

Interventions

Intervention1: nil: nil

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any patient above 18 years of age with following complaints Nasal blockade or congestion, nasal discharge (bloody or brown/black), local pain Pain, numbness or swelling of facial skin Headache or blurred or double vision withpainin Toothache, loosening of maxillary teeth, jaw involvement 2. COVID -19 positive on nasopharyngeal RT-PCR or Chest CT suggestive of COVID- 19 less than 2 months old with mucormycosis confirmed on histopathology. Both criteria 1 and 2 must be met for inclusion in the study.

Exclusion criteria

Exclusion criteria: Mucormycosis cases without a confirmed bout of preceding COVID-19

Design outcomes

Primary

MeasureTime frame
To identify the risk factors in causation of mucormycosis in COVID -19 patients.Timepoint: at baseline—

Secondary

MeasureTime frame
To study the demographic profile and presenting features of mucormycosis following COVID-19 during the second waveTimepoint: at the time of baseline—

Countries

India

Contacts

Public ContactRavi Meher

Maulana Azad Medical College

ravimeher@gmail.com9968604237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026